RINVOQ® (upadacitinib) Safety and Clinical Experience
Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis | Arthritis Research & Therapy | Full Text